Mosaicism of BRAF V600E in Healthy Skin Predicts Neurodegeneration in Histiocytosis
Emile, J.-F.; Helias-Rodzewicz, Z.; Papo, M.; Ungureanu, I. A.; Baek, c.; Triboulet, f.; Wong, T. H.; Jannet, R. B.; Terrones, N.; Qalli, S. E.; Suret, p. m.; Reig, B.; Atallah, A.; Semenov, A.; DEGRAVE, R.; Nguyen, m.; Sutera, r.; Siliogka, E.; Cariou, P. L.; Prevost, g.; DE LA ROCHEFOUCAULD, J.; Biassette, H. A.; Plu, i.; Mathian, a.; CATELAIN, C.; Razanamahery, j.; Ewenczyk, c.; Heritier, s.; Aubart, F. C.; Hirsch, p.; Amoura, Z.; Donadieu, J.; Idbaih, A.; Haroche, J.
Show abstract
Most histiocytoses harbor an oncogenic somatic alteration activating the MAP kinase pathway, the most frequent of which is BRAFV600E. Targeted therapy with BRAF or MEK inhibitors is highly effective, but neurodegeneration remains a severe complication. Recent data suggest that neurodegeneration may be secondary to mosaicism for BRAFV600E in microglia. In the prospective observational TARGET-HISTIO cohort study, we investigated extra-CNS mosaicism of BRAFV600E in a cohort of 124 adults with histiocytosis. Seeking widespread mosaicism, we analyzed healthy skin biopsies from areas without histiocytosis or melanocytic infiltration using high-sensitivity digital polymerase chain reaction. BRAFV600Ewas detected in healthy skin in 57/67 (85%) patients with BRAFV600Ehistiocytosis and was present in all second and third skin biopsies (n=6). BRAFV600Ewas absent from skin biopsies in all 37 patients with histiocytosis harboring another oncogenic mutation. BRAFV600E was also present in skin biopsies of four /20 patients with histiocytosis of unknown molecular status. Cells harboring BRAFV600E share characteristics with resident dermis macrophages. Only 58% of patients with BRAFV600E in skin also had BRAFV600E in blood leukocytes. Variant allele frequency in skin and blood leukocytes was 16 times lower than in histiocytosis, and frequency in skin was independent of treatment with BRAF/MEK inhibitors. None of the patients with wild type BRAF alleles in skin had neurodegeneration, whereas 22/61 (36%) of patients with BRAFV600E in skin had neurodegeneration. This study demonstrates that mosaicism of BRAFV600Ein healthy skin is frequent in patients with histiocytosis and is strongly associated with neurodegeneration. Key PointsLow allele frequency of the oncogene BRAF V600E is frequent in healthy skin of patients with histiocytosis. Patients without BRAF V600E in skin do not develop neurodegeneration, while 36% of those with BRAF V600E mosaicism do.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Nuclear depletion of RNA binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis 90%
- TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy 89%
- Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure 88%
Similar papers in this journal
- High-Throughput, Multiplex Immunofluorescence for the Computer-automated Immunophenotyping of Mycosis Fungoides 89%
- Atopic dermatitis complicated by recurrent eczema herpeticum is characterized by multiple, concurrent epidermal inflammatory endotypes 89%
- The human Flower isoform hFWE4 facilitates cornification in cutaneous squamous cell carcinoma 88%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype 91%
- Complement activity in myasthenia gravis is independent of autoantibody titer and disease severity 90%
- Immortalization and Characterization of Schwann Cell Lines Derived from NF1 Associated Cutaneous Neurofibromas 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.